French Pharma Firm Ordered to Pay Millions Over Deadly Diabetes Drug

FILE - An operator holds and checks tablets in a laboratory of the French pharmaceutical company Servier on Sept. 1, 2017. A French appeals court ordered Servier to pay more than $460 million in damages over a diabetes drug on Dec. 20, 2023.

A French appeals court on Wednesday ordered pharmaceutical firm Servier to pay more than $460 million in damages over a scandal involving a diabetes drug linked to hundreds of deaths.